SCHEMBL16229752

SCHEMBL16229752

CN1C2C1C21Cc2ccc(OCCNS(=O)(=O)c3cnn(C)c3)cc2C1Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 14/20 0.52
KCNH2 Q12809 2/20 0.46
HTR1A P08908 3/20 0.40
HTR7 P34969 3/20 0.40
ALDH1A1 P00352 1/20 0.39
SLC8A1 P32418 1/20 0.39
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16784630 0.92 SLC6A9 (0.54) SLC6A9KCNH2HTR1AHTR7
SCHEMBL16784653 0.92 SLC6A9 (0.51) SLC6A9KCNH2HTR1AHTR7SLC8A1
SCHEMBL16784632 0.90 SLC6A9 (0.52) SLC6A9KCNH2HTR1AHTR7ALDH1A1
SCHEMBL16784640 0.88 SLC6A9 (0.41) SLC6A9KCNH2HTR1AHTR7ALDH1A1
SCHEMBL16229746 0.87 HTT (0.40) SLC6A9ALDH1A1SLC8A1HTT
SCHEMBL16229774 0.86 SLC6A9 (0.65) SLC6A9KCNH2SLC8A1MEN1KMT2A
SCHEMBL16784645 0.85 SLC6A9 (0.41) SLC6A9HTR1AHTR7ALDH1A1SLC8A1
SCHEMBL16229750 0.82 SLC6A9 (0.46) SLC6A9KCNH2
SCHEMBL16229745 0.82 SLC6A9 (0.60) SLC6A9KCNH2
SCHEMBL13738310 0.81 SLC6A9 (0.55) SLC6A9KCNH2HTR1AHTR7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051280-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-09 US disclosed
US-8883839-B2 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy ABBOTT LABORATORIES (US) 2014-11-11 US disclosed